AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05932303 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Itraconazole
Description: Specified dose on specified days
Study NCT05932303 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Description: Specified dose on specified days
Study NCT05932303 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carbamazepine
Description: Specified dose on specified days
Study NCT05875909 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: corneal flap transplantation
Description: Patients with macular holes underwent a 25-gauge, 3-port pars plana vitrectomy . Fluid-air exchange was performed in patients with pathologic myopia suffering from macular holes with retinal detachment. We used a flute needle to drain the subretinal fluid. A corneal flap was obtained by small incision lenticule extraction (SMILE). Stripping pliers were applied to spread corneal flap over the macular hole. A drop of fresh autologous whole blood was dripped over the corneal flap to immobilise it. The vitreous cavity was filled with 14% perfluoropropane (C3F8) for macular holes with retinal detachment . The surgical incision was self-closed or sutured with a 6-0 polyglactin 910 suture . The patients were instructed to maintain a prone position for 2 weeks postoperatively.
Study NCT04253652 — intervention group
Intervention type: OTHER
Intervention: Fasted breath samples
Description: Will be completed pre and post iron therapy
Study NCT04253652 — intervention group
Intervention type: OTHER
Intervention: IBS-SSS
Description: Will be completed pre and post iron therapy
Study NCT04253652 — intervention group
Intervention type: OTHER
Intervention: Daily diary
Description: Monitoring stool form, consistency and frequency on a daily basis for 4 weeks
Study NCT04253652 — intervention group
Intervention type: OTHER
Intervention: Exploratory research: stool samples
Description: Completed pre and post iron therapy for a subset of patients enrolled in the study
Study NCT05223374 — intervention group
Intervention type: DEVICE
Intervention: Canvas Dx
Description: Canvas Dx is intended for use by healthcare providers as an aid in the diagnosis of autism spectrum disorder (ASD) for patients ages 18 months through 72 months who are at risk for developmental delay based on concerns of a parent, caregiver, or healthcare provider. The device is not intended for use as a stand-alone diagnostic device but as an adjunct to the diagnostic process. The device is for prescription use only (Rx only)
Study NCT06313242 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Polyethylene Glycol Electrolytes Powder (II)
Description: Polyethylene Glycol Electrolytes Powder (II) was used for bowel preparation.
Study NCT06313242 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low residue diet
Description: Low residue diet 1 day before the test, fasting from 20:00 pm.
Study NCT06313242 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Normal diet
Description: Normal diet 1 day before the test, fasting from 20:00 pm.
Study NCT04576962 — intervention group
Intervention type: OTHER
Intervention: Immunization Information System Review
Description: Extraction of county- and state-level data on HPV vaccine completion from Indiana's Immunization Information System
Study NCT06596694 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Patritumab deruxtecan
Description: Administered via intravenous (IV) infusion
Study NCT05585515 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep deprivation
Description: Total sleep deficit of consecutive 8 hours
Study NCT05585515 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep restriction
Description: Total sleep deficit of cumulative 8 hours
Study NCT04660721 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: sFilm-FS
Description: sFilm-FS is a sterile bio-compatible bio-absorbable patch embedded with lyophilized powders of Human Fibrinogen, Human Thrombin and calcium chloride.
Study NCT04660721 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: TACHOSIL®
Description: TACHOSIL® is a fibrin sealant patch composed of an equine collagen patch coated with Human Fibrinogen and Human Thrombin.
Study NCT05489900 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine Hydrochloride
Description: Dexmedetomidine is a specific and potent α2-adrenergic agonist. By acting directly on the sympathetic nervous system, they can exert beneficial effects on the immune system through neuroimmune interactions. Its administration can induce an anti-inflammatory response due to different central (increase parasympathetic tone, promoting control of the inflammatory condition) and peripheral effects (stimulating innate immunity).(MILLER, 2015).~Venous blood samples were collected at three times (T1, T2 and T3): Before anesthetic induction with collection in the preoperative environment on the day of surgery or during venoclysis before anesthetic induction (sample 1, T1); 6 hours after starting orifice closure and completion of drug or placebo infusion (sample 2, T2); and the last blood sample will be collected by me on the morning after the postoperative period, close to hospital discharge - 24h (sample 3, T3).
Study NCT06262256 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High-intensity interval training
Description: supervised exercise conducted on stationary bikes after individualized intensity prescription.
Study NCT05202821 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PRG Barrier Coat
Description: 3 arm randomized single blind clinical trial comparing 3 groups. first group will be receiving fluoride varnish, second group will be receiving PRG Barrier Coat and the third group will be receiving MI paste
Study NCT05202821 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluoride varnish
Description: First group will be receiving Fluoride varnish every 3 months
Study NCT05202821 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: MI paste
Description: Third group will be receiving MI paste
Study NCT05558566 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neurofeedback from the SMA
Description: Feedback is provided regarding activity in the SMA and participant attempts to control SMA activity using the feedback as a training signal
Study NCT05558566 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Neurofeedback from control region
Description: Feedback is provided regarding activity in a control region and participant attempts to control activity in that region using the feedback as a training signal.
Study NCT06463522 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Autologous Tumor-infiltrating Lymphocytes
Description: Autologous Tumor-infiltrating Lymphocytes, 2.0\*10\^7/Kg, single intravenous infusion.
Study NCT05217420 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Moving Well
Description: Experimental arm
Study NCT05217420 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Staying Well
Description: Active comparator arm
Study NCT05135520 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transvaginal natural orifice specimen extraction (NOSE)
Description: Under general anesthesia, patients who are planned to perform multiport laparoscopic surgery for resection of solid organs including kidney or bladder will undergo Transvaginal NOSE
Study NCT05135520 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transabdominal specimen extraction
Description: Under general anesthesia, patients who are planned to perform multiport laparoscopic surgery for resection of solid organs including kidney or bladder will undergo transabdominal specimen extraction with incision elongation
Study NCT05506852 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Web-based training strategy
Description: Participants will undergo a web-based training protocol where they will play an online game that simulates a breakfast environment and will perform everyday activities as cooking and setting tables in a multi-tasking fashion. Participants will learn to play the game using specific strategies, in order to optimize the performance.
Study NCT05506852 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Web-based regular training (no strategy)
Description: Participants will undergo a web-based training protocol where they will play an online game that simulates a breakfast environment and will perform everyday activities as cooking and setting tables in a multi-tasking fashion. Participants will learn to play the game under regular game instructions.
Study NCT05982509 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EasyDew Regen MD Cream
Description: For the study group, I received the prescription Easy Dew Regen MD Cream from Picosure Laser Apply an appropriate amount twice a day (morning and evening) to the skin of the area so that it can be absorbed well do. The control group is the non-chalant group. However, for one month after the procedure, it is not a medical device The normal moisturizer you use at home is available, and the area where you have undergone laser treatment Apply it twice a day (morning and evening) to the skin so that it can be absorbed well.
Study NCT06269497 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Scaffold placement
Description: The scaffold is placed in the alveola following extraction
Study NCT06269497 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: CBCT
Description: A Cone Beam Computer Tomography (CBCT) is taken of the area of interest after surgery
Study NCT05414825 — intervention group
Intervention type: OTHER
Intervention: focus group interview
Description: Group interview gathering words, views, symptoms and its repercussions, and main issues of the subjects regarding severe dysmenorrhea
Study NCT04390217 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LB1148
Description: LB1148 is delivered orally/enterally, 700 mL per day split into two administrations of 350 mL, approximately 12 hours apart, for up to 7 days.
Study NCT04390217 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo is delivered orally/enterally, 700 mL per day split into two administrations of 350 mL, approximately 12 hours apart, for up to 7 days.
Study NCT06271252 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OriCAR-017
Description: Anti-GPRC5D CAR-T cell product
Study NCT05038202 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bencycloquidium Bromide Nasal Spray
Description: The content of this product is a colorless and clear liquid, press the sprayer, the liquid will be sprayed out in mist.~This product is suitable for improving the symptoms of runny nose, nasal congestion, nasal itching and sneezing caused by allergic rhinitis.
Study NCT05038202 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mometasone Furoate Aqueous Nasal Spray
Description: Mometasone furoate nasal spray is a quantitative hand-press spray device, and the content is a white to off-white suspension.~This product is suitable for the treatment of seasonal or perennial rhinitis in adults, adolescents and children from 3 to 11 years old. For patients who have had moderate to severe seasonal allergic rhinitis symptoms, it is recommended to use this product 2-4 weeks before the start of the pollen season Preventive treatment.
Study NCT05038202 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mometasone Furoate Aqueous Nasal Spray
Description: Mometasone furoate nasal spray is a quantitative hand-press spray device, and the content is a white to off-white suspension.~This product is suitable for the treatment of seasonal or perennial rhinitis in adults, adolescents and children from 3 to 11 years old. For patients who have had moderate to severe seasonal allergic rhinitis symptoms, it is recommended to use this product 2-4 weeks before the start of the pollen season Preventive treatment.
Study NCT05485025 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tai chi training
Description: Tai chi, also called tai chi chuan, is an ancient Chinese form of exercise originally created as a fighting art. It is a kind of gentle physical exercise and stretching, which involves a series of movements performed in a slow, focused manner and accompanied by deep breathing.
Study NCT05485025 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group activity
Description: A organizer will lead the subjects to participate in group activities once a quarter. In group activities, there will be popular science lectures and interactive games.
Study NCT06673745 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: IASTM
Description: Group A received IASTM treatment, which will be given by the Edge tool, that is an ergonomically designed stainless steel instrument and offers several different hand holds, eliminating operator fatigue. Prior to the treatment, the IASTM therapeutic effects will be explained. The scanning assessment will be done to identify areas of restrictions directed by the gritty sensations using the Edge tool. Each restriction will be treated with the tool for 30-60 sec and given. This treatment will be given for 30 minutes for 3 days per week for 4 weeks
Study NCT06673745 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dynamic cupping therapy
Description: On the contrary, group B the patient will be seated in a chair with the elbow flexed on the plinth to relax the forearm muscles. The area around the elbow joint will be cleaned with alcohol to remove any foreign bodies from the treated area. Dynamic cupping therapy for elbow stiffness will begin with an assessment of the patient\&amp;#39;s condition, where factors such as the extent of stiffness and range of motion in the elbow joint will be evaluated. Following this assessment, lubricant will be applied to the skin surrounding the elbow to facilitate smooth movement of the cups. Cups of suitable size and material will then be strategically placed around the elbow joint, and suction will be created inside each cup to create a vacuum effect. Once thesecurely attached, the practitioner will move them around the elbow area using gentle techniques such as gliding or pumping motions.
Study NCT05223478 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Phentolamine Ophthalmic Solution 0.75%
Description: 0.75% phentolamine ophthalmic solution (Nyxol), a non-selective alpha-1 and alpha-2 adrenergic antagonist
Study NCT05223478 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Phentolamine Ophthalmic Solution Vehicle
Description: Phentolamine Ophthalmic Solution Vehicle
Study NCT05490849 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 68Ga-HX01
Description: For pharmacokinetics, healthy volunteer underwent 68Ga-HX01 PET imaging. Blood samples were collected at 25 min, 55 min, and 115 min after imaging agent injection, and urine specimens were collected at 28 min, 58 min, and 118 min after injection to measure radioactivity in blood and urine. PET/MR scans were performed at 30-50 min, 60-80 min, and 120-140 min after injection to understand absorption, distribution, and metabolism.~Cancer patients,~1. Subjects should have 68Ga-HX01 and 18F-FDG PET scans two days apart.~2. Blood tests, liver and kidney function, tumor markers (CA125, CA199, CEA, etc.), and other biochemical markers must be performed one week prior to and after imaging.~3. Tumor biopsies or surgical specimens should be evaluated histopathologically and immunostained for biomarkers associated with angiogenesis.
Study NCT06380959 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Art Based Activity
Description: Art Based Activity Module consists of 3 art-based activities under the titles My Life Journey, The Power Within Me and Letter to the Future. Each activity consists of three stages. In the first stage, the participants were made to practice breathing exercises. At this stage, the participant was expected to become aware of himself and his ideas. In the second stage, art activity was carried out. In the final stage, the revealed art object was concretized by the participants with a verbal expression. The materials used in the activities (dry paint, pastel paint, watercolor) are dermatologically tested and consist of anti-allergen products.
Study NCT06268561 — intervention group
Intervention type: OTHER
Intervention: Visual acuity analysis
Description: Collection of information on visual acuity from the medical file concerning the surgery
Study NCT06268561 — intervention group
Intervention type: OTHER
Intervention: Intraocular pressure analysis
Description: Collection of information on intraocular pressure from the medical file concerning the surgery
Study NCT06268561 — intervention group
Intervention type: OTHER
Intervention: Analysis of optical coherence tomography (OCT) images
Description: Collection and analysis of optical coherence tomography (OCT) images of the medical file concerning the surgery
Study NCT04850092 — intervention group
Intervention type: OTHER
Intervention: Positional change from supine to prone
Description: Patient is turned from supine to prone position for spine surgery
Study NCT03989778 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vitamin D
Description: Vitamin D supplementation
Study NCT05454332 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Early Caffeine administration
Description: Blinding will be done with the administration of saline solution. Patients in the early caffeine group will receive an attack dose of caffeine 20 mg/kg and begin maintenance dose 10 mg/kg/day. Patients in the late caffeine group, receive bolus of saline solution in the first 2 hours of life, starting, at 24 hours of life, the caffeine-loading dose 20 mg/kg and after maintenance dose 10mg/kg/day. The medical team will prescribe the medication, and the pharmacy will be responsible for randomly dispensing the caffeine or saline solution. The pharmacy will prepare syringes with the medication or saline solution identified by a code referring to the randomization without identifying which solution is being administered. The syringes will be sent to the neonatal ICU and will be administered according to the physician's prescription. The administration will be blinded.
Study NCT05454332 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Group
Description: Blinding will be done with the administration of saline solution. Patients in the early caffeine group will receive an attack dose of caffeine 20 mg/kg and begin maintenance dose 10 mg/kg/day. Patients in the late caffeine group, receive bolus of saline solution in the first 2 hours of life, starting, at 24 hours of life, the caffeine-loading dose 20 mg/kg and after maintenance dose 10mg/kg/day. The medical team will prescribe the medication, and the pharmacy will be responsible for randomly dispensing the caffeine or saline solution. The pharmacy will prepare syringes with the medication or saline solution identified by a code referring to the randomization without identifying which solution is being administered. The syringes will be sent to the neonatal ICU and will be administered according to the physician's prescription. The administration will be blinded.
Study NCT06500910 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical Exercise
Description: 10 weeks of child-friendly physical exercise program
Study NCT05536869 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Caesarean
Description: Two different caesarean section techniques : intra or extraperitoneal
Study NCT06268561 — intervention group
Intervention type: OTHER
Intervention: Analysis of retinograms
Description: Collection and analysis of retinography images of the medical file concerning the surgery
Study NCT05536869 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Caesarean
Description: Two different caesarean section techniques : intra or extraperitoneal
Study NCT04934046 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Additional acquisition
Description: Additional SPECT acquisition (30min added time approximately), with no added radiation
Study NCT05378555 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine Hydrochloride
Description: All patients in this study will receive oral ketamine for the treatment of pain from vaso-occlusive crisis. Patients will receive 0.5 mg/kg ketamine Q8hrs for 48 hours.
Study NCT06318312 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hypoxia
Description: Hypoxic exposure: FiO2 = 11% Hypoxic exposure: FiO2 = 13% Hypoxic exposure: FiO2 = 15% Hypoxic exposure / placebo: FiO2 = 21%
Study NCT06318312 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Hypoxia
Description: Hypoxic exposure: FiO2 = 11% Hypoxic exposure: FiO2 = 13% Hypoxic exposure: FiO2 = 15% Hypoxic exposure / placebo: FiO2 = 21%
Study NCT06347250 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Nerve Block
Description: The percutaneous approach via the paratracheal route was used for Stellate ganglion block. The operator stood on the side of the block, instructed the patient to lie supine with a thin pillow placed below the shoulders, and tilted the head 45° towards the blocked side, fully exposing the neck. Then, routine disinfection of the neck skin was performed. The puncture site was located 2.5 cm above the sternoclavicular joint and 1.5 cm lateral to the midline of the neck.
Study NCT06347250 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine Hydrochloride
Description: the patients were provided with Stellate ganglion block, using 1.5ml of 2% Lidocaine hydrochloride (1ml: 0.5mg) and 500ug of Vitamin B12 (1ml: 0.5g).
Study NCT06347250 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: routine therapy
Description: All the participants are provided with the comprehensive rehabilitation (routine rehabilitation and swallowing function training). The routine rehabilitation included intervention for risk factors (blood pressure, blood lipids, blood glucose, smoking and alcohol restriction, exercise, etc.).~Regrading swallowing function training, both groups are given swallowing function training, including 1) exercises of closure of the vocal folds, pharyngeal, and laryngeal muscles exercises, and respiratory muscle strength training, for 15 min each time and twice per day. 2) isotonic／isometric swallowing exercises, supraglottic swallowing exercises, for 20 min each time and twice per day. 3) effortful swallowing exercises, and cough reflex training, for 10 min each time and twice per day.